Results 71 to 80 of about 2,073 (215)

„Stärkerer Fokus auf die Methoden der Studiendurchführung“

Monitor Versorgungsforschung
Nach Prof. Dr. med. Peter Sawicki (2004 bis 2009) und Prof. Dr. med. Jürgen Windeler (2010 bis März 2023) ist seit April 2023 Dr. med. Thomas Kaiser der dritte Leiter des Instituts für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG).
Dr. med. Thomas Kaiser, Peter Stegmaier
doaj   +1 more source

Opportunities to improve the adoption of health-related quality of life evidence as part of the French Health Technology Assessment process

Health Research Policy and Systems, 2023
Objectives Patient’s health-related quality of life (HRQoL) is an important outcome measure that is considered by many payers and health technology assessment (HTA) bodies in the evaluation of treatments.
Hugo Larose, Myrto Lee, Jens Grueger, Amélie Anota, Nicolas Naïditch, Bruno Falissard, Mario Di Palma, Olivier Chassany, Laura Khalfallah-Neelz, Sarah Palazuelos-Muñoz, Aymeric Tetafort   +10 more
doaj   +1 more source

Complex, low‐intensity, individualised naturalistic developmental behavioural intervention in toddlers and pre‐schoolers with autism spectrum disorder: The multicentre, observer‐blind, parallel‐group randomised‐controlled A‐FFIP trial

Journal of Child Psychology and Psychiatry, Volume 66, Issue 10, Page 1500-1513, October 2025.
Background Naturalistic developmental behavioural interventions (NDBI) may improve social communication in toddlers/pre‐school aged children with autism spectrum disorder (ASD). Here, we study efficacy of the low‐intensity, complex NDBI ‘Frankfurt Early Intervention Program for ASD’ (A‐FFIP) over 1 year by a confirmatory phase‐III, prospective ...
Christine M. Freitag, Marietta Kirchner, Lukas D. Sauer, Solvejg K. Kleber, Leonie Polzer, Naisan Raji, Christian Lemler, Ulrike Fröhlich, Tomasz Jarczok, Julia Geissler, Franziska Radtke, Melanie Ring, Veit Roessner, Regina Taurines, Michelle Noterdaeme, Karoline Teufel, Ziyon Kim, Janina Kitzerow‐Cleven   +17 more
wiley   +1 more source

OP94 Is The National Institute for Health And Care Excellence In The United Kingdom More Innovation-Friendly Than The German Institute For Quality And Efficiency in Health Care In Germany? [PDF]

, 2017
INTRODUCTION:Whereas Health Technology Assessments (HTAs) by the National Institute for Health and Care Excellence (NICE) rely heavily on cost utility analysis, HTAs by the German Institute for Quality and Efficiency in Health Care (IQWiG) and the ...
Michael Schlander, Ramon Schaefer
core   +1 more source

A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency

BMC Health Services Research, 2020
Background Value-based pricing (VBP) of new drugs has been suggested both as a way to control health expenditures and to maximize health benefits based on the available resources. The purpose of this work is to present a simple mathematical proof showing
Afschin Gandjour
doaj   +1 more source

Transcranial Direct Current Stimulation of the Temporoparietal Junction in Autism Spectrum Disorder: Results of a Phase‐IIa Randomized, Double‐Blind, Sham‐Controlled Feasibility Study

Autism Research, Volume 18, Issue 9, Page 1861-1876, September 2025.
ABSTRACT Activation of the temporoparietal junction (TPJ) is reduced in autism spectrum disorder (ASD) during social cognitive tasks. Therefore, anodal transcranial direct current stimulation (tDCS) of the TPJ may enhance social cognitive abilities in autistic individuals. In a multicenter, randomized, sham‐controlled, double‐blind parallel‐group Phase‐
Christina Luckhardt, Magdalena Schütz, Andreas M. Mühlherr, Sara Boxhoorn, Christine Ecker, Hanna Mössinger, Julia Siemann, Fabienne Schlechter, Miguel Castelo‐Branco, Helena C. Pereira, Marianne Latinus, Camille Ricou, Frederique Bonnet‐Brilhault, Ricardo Salvador, Giulio Ruffini, Rafal Nowak, Michael Siniatchkin, Astrid Dempfle, Christine M. Freitag   +18 more
wiley   +1 more source

Stellungnahmerecht der Fachgesellschaften gesetzlich verankert [PDF]

, 2011
Mit der Verabschiedung des Versorgungsstrukturgesetzes sind weitere Stellungnahmerechte der Fachgesellschaften gesetzlich im SGB V verankert - die AWMF organisiert den Kontakt zu G-BA, IQWiG und ...
Müller, W
core   +1 more source

Prognostic Factors and Effect Modifiers in Patients With Relapse or Refractory Diffuse Large B‐Cell Lymphoma After Two Lines of Therapy: A Systematic Literature and Expert Clinical Review

European Journal of Haematology, Volume 115, Issue 2, Page 104-116, August 2025.
ABSTRACT Objectives The objective of this systematic literature review (SLR) combined with expert clinical review was to identify and rank prognostic factors and effect measure modifiers (EMMs) systematically and comprehensively in patients with relapsed or refractory (R/R) diffuse large B‐cell lymphoma (DLBCL) who initiate treatment after ≥ 2 prior ...
Bastian von Tresckow, Pau Abrisqueta, Irene Zamanillo, Ángel Serna, Yuting Kuang, Jennifer Uyei, Mohsin Shah, Laura Walsh, Eileen Thorley, Krystal Cantos, Emaan Rashidi, Christian Hampp, Jessica J. Jalbert, Alexi N. Archambault, Yingxin Xu, Shivani Aggarwal, Srikanth Ambati, Hesham Mohamed, Qiufei Ma, Ana Jiménez‐Ubieto   +19 more
wiley   +1 more source

Daratumumab (neues Anwendungsgebiet, Multiples Myelom, für Stammzelltransplantation nicht geeignet, Erstlinie) [PDF]

Dieses Verfahren betrifft eine weitere Anwendung von Daratumumab (Darzalex®) in der Erstlinientherapie des Multiplen Myeloms bei Patienten, die nicht für eine autologe Stammzelltransplantation geeignet sind.
Weisel, Katja, Wörmann, Bernhard, Deutsche Studiengruppe Multiples Myelom (DSMM), Goldschmidt, Hartmut, Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie, Deutschland. Gemeinsamer Bundesausschuss, German-Speaking Myeloma Multicenter Group (GMMG), Scheid, Christoph, Einsele, Hermann, Knop, Stefan, Röllig, Christoph   +10 more
core   +3 more sources

Machbarkeit und Praktikabilität der anwendungsbegleitenden Datenerhebung (AbD) - Erfahrungen, Analysen und Weiterentwicklungsvorschläge

Monitor Versorgungsforschung
Der Gesetzgeber hat mit dem 2019 eingeführten Instrument der anwendungsbegleitenden Datenerhebung (AbD) die Möglichkeit geschaffen, vergleichende Daten in der laufenden Versorgung zu erheben.
Dr. rer. nat. Matthias Wilken, Fabian Berkemeier MSc   +1 more
doaj   +1 more source